•
AS
ASND
Ascendis Pharma A/S American Depositary Shares
yahoo--
Price Chart
Market Cap
13.24B
Volume
3.51K
52W High
$229.94
52W Low
$118.03
Open
$0.00
Prev Close
$216.66
Day Range
0.00 - 0.00
About Ascendis Pharma A/S American Depositary Shares
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.
Latest News
Ascendis Pharma Provides Business and Strategic Roadmap Update at 44th Annual J.P. Morgan Healthcare Conference
GlobeNewswire Inc.•Jan 9
Ascendis Announces Extension of FDA Review Period for TransCon CNP (navepegritide) for Children with Achondroplasia
GlobeNewswire Inc.•Nov 25
Why Is BioMarin Stock Trading Higher On Thursday?
Benzinga•Feb 20
Wegovy Manufacturer Inks Multi-Million Deal For Monthly Obesity Drug
Benzinga•Nov 4
BioMarin Stands Firm on 2027 Revenue Target Amid Ascendis Competition, Goldman Sachs Analyst Remains Bullish
Benzinga•Sep 25
Bausch & Lomb And Edgewise Therapeutics Are Among Top 7 Mid Cap Stock Gainers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?
Benzinga•Sep 22
Ascendis Pharma A/S Announces Pricing of Public Offering of ADSs
GlobeNewswire Inc.•Sep 20
Eyconis, Inc. Announces Appointment of Dr. Mark J. Bachleda as Chief Executive Officer and Member of the Board of Directors
GlobeNewswire Inc.•Sep 19